Mechanisms of Secondary Leukemia Development Caused by Treatment with DNA Topoisomerase Inhibitors.

Lomov, Nikolai A; Viushkov, Vladimir S; Rubtsov, Mikhail A

Lomov, Nikolai A; Viushkov, Vladimir S; Rubtsov, Mikhail A.

Afiliação

Lomov NA; Department of Molecular Biology, Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia. lomov@mail.bio.msu.ru.
Viushkov VS; Department of Molecular Biology, Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.
Rubtsov MA; Department of Molecular Biology, Faculty of Biology, Lomonosov Moscow State University, Moscow, 119234, Russia.

Biochemistry (Mosc) ; 88(7): 892-911, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37751862

Assuntos

Neoplasias Hematológicas; Leucemia; Humanos; Inibidores da Topoisomerase II/efeitos adversos; Translocação Genética; Leucemia/induzido quimicamente; Leucemia/tratamento farmacológico; Leucemia/genética; Quebras de DNA de Cadeia Dupla

Palavras-chave

DNA topoisomerase II inhibitors; fusion proteins; leukemia; translocations

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia / Neoplasias Hematológicas Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google